NCT06327100: Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 33 planned
- Started
- 1 Aug 2024
- Primary completion
- 1 May 2029
- Arms
- Group 1
- Results
- None posted
- 25 Mar 2024: Trial registered
- 1 Aug 2024: Trial started